These observations suggest that anti-GRP78 antibodies produced in cancer patients are functionally synthesized to protect the target tissue from immune responses, providing the tumor with defensive mechanisms that facilitate cell survival and proliferation. This evidence concerns the gene HSPA5 and cancer.